A targeted infusion for certain forms of Duchenne muscular dystrophy

Casimersen

A targeted medicine used for certain forms of Duchenne muscular dystrophy suitable for exon-45 skipping.

What is Casimersen?

Casimersen is a specialist targeted medicine used to treat Duchenne muscular dystrophy in people whose genetic fault is suitable for what is called exon-45 skipping. It is given as a regular infusion into a vein and works by helping muscle cells make a more usable form of the dystrophin protein that is missing in this condition. It is generally well tolerated, and the main practical points are the need for regular infusions and for monitoring kidney function over time. It is a long-term treatment given under specialist care.

Education and reference only. This is a plain-language guide to Casimersen — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.

Brands: Amondys 45
Casimersen (Antisense therapy (Duchenne muscular dystrophy)) — Meds Global Health reference card
Casimersen — Antisense therapy (Duchenne muscular dystrophy).

What it is

Casimersen is a targeted medicine, known as an antisense therapy, used in Duchenne muscular dystrophy, an inherited condition in which muscles gradually weaken because the body cannot make a working muscle protein called dystrophin. It is only suitable for people whose specific genetic change can be helped by 'skipping' a particular part of the gene known as exon 45. It is given as a regular infusion into a vein, under the care of a specialist neuromuscular team, and is a long-term treatment.

How it works

In Duchenne muscular dystrophy, a fault in the dystrophin gene stops muscle cells making working dystrophin, the protein that keeps muscle fibres strong. Casimersen is designed to make the cell's machinery 'skip over' a faulty part of the gene (exon 45) when reading it, so that a shorter but more usable form of dystrophin can be produced. The aim is to help muscle cells make some functional protein and slow the weakening of the muscles. Because it only works for people whose genetic change suits exon-45 skipping, a genetic test is needed first, and it is given regularly to keep the effect going.

Company & origin

Originated / developed by: Specialist manufacturer.

A specialist targeted medicine used for certain forms of Duchenne muscular dystrophy that are suitable for skipping a particular part of the dystrophin gene.

Practical use

How to take Casimersen

General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.

  • It is given as an infusion into a vein on a regular schedule arranged by the specialist team.
  • Make sure the genetic test confirming exon-45 suitability has been done before starting.
  • Attend the planned infusion appointments, as it needs to be given regularly to keep working.
  • Have the blood and urine tests arranged to check kidney function over time.
  • Report any new symptoms, such as a reaction during an infusion, to the team.

Weighing it up

Advantages & disadvantages of Casimersen

Advantages

  • Targets the underlying genetic fault in suitable people, aiming to slow muscle weakening.
  • Generally well tolerated, with mostly mild reported side effects.
  • Helps muscle cells make a more usable form of the missing dystrophin protein.

Disadvantages

  • Only works for people whose genetic change suits exon-45 skipping, confirmed by testing.
  • Given as a regular infusion into a vein rather than as a tablet.
  • Needs ongoing kidney monitoring and is a long-term treatment that does not cure the condition.

Practical use

Good to know

The first thing to understand is that casimersen only suits people whose specific genetic change is amenable to exon-45 skipping, which is confirmed by genetic testing before treatment. It is given as a regular infusion into a vein, so treatment involves attending for these infusions, often through a planned schedule. It is generally well tolerated; the most reported effects are mild, such as headache, cough, fever, tummy pain or joint aches. An important monitoring point is the kidneys: because this type of medicine is cleared by the kidneys, kidney function is checked over time. It is a treatment that aims to slow muscle weakening rather than cure the condition, and it is used as part of overall specialist care for Duchenne muscular dystrophy.

Who should not take it / use with caution

  • It is only suitable for people whose genetic change is amenable to exon-45 skipping, confirmed by testing.
  • People who have had a serious allergic reaction to casimersen should not receive it.
  • It is used with care, with kidney monitoring, in people with kidney problems, under specialist supervision.

Monitoring

  • Checking kidney function with blood and urine tests over time.
  • Watching for reactions during and after infusions.
  • Reviewing muscle strength and overall progress as part of specialist care.

Side effects

  • Generally well tolerated, with mostly mild effects.
  • Headache, cough, fever or feeling generally unwell.
  • Tummy pain, joint aches or pain at the site where the infusion is given.
  • Rarely, an allergic-type reaction during or after an infusion, which should be reported.

Key interactions

  • There are few well-established routine medicine interactions, but tell the team about all medicines taken.
  • Other medicines that can affect the kidneys may need reviewing, given how this medicine is cleared.
  • Always give the specialist team a full list of medicines and supplements.

Available as: A solution given as an infusion into a vein.

Answers

Casimersen: frequently asked questions

What is casimersen used for?

It is a targeted medicine for Duchenne muscular dystrophy in people whose genetic fault is suitable for exon-45 skipping, helping muscle cells make a more usable form of the missing protein.

How is it given?

It is given as a regular infusion into a vein, on a schedule arranged by the specialist neuromuscular team.

Will it work for everyone with Duchenne muscular dystrophy?

No. It only works for people whose specific genetic change suits exon-45 skipping, which is confirmed by a genetic test before starting.

Is it well tolerated?

It is generally well tolerated, with mostly mild reported effects such as headache, cough, fever or joint aches.

Why are my kidneys monitored?

This type of medicine is cleared by the kidneys, so kidney function is checked over time with blood and urine tests as a precaution.

Authoritative sources

  • BNF
  • NICE CKS

Building a medicines information resource?

We create evidence-led, dose-free drug and formulary references for teams.

☎ Call Get a Proposal